Efficacy and Safety of SurgiFill™in Patients With Femur or Tibia Fracture

A Clinical Trial to Investigate the Safety and Efficacy of SurgiFill™, a Bone Grafting Material, in Patients With Femur or Tibia Fracture.

This study is designed to investigate the safety and efficacy of SurgiFill™, a bone grafting material, in patients with femur or tibia fracture.

Study Overview

• Status: Terminated
• Conditions: Femur Fracture; Bone Fracture; Tibia Fracture
• Intervention / Treatment: Procedure: femur or tibia fracture; Device: SurgiFill™

Detailed Description

This study is an open-trial study. The purpose and procedure of study will be explained to the subjects, and they will voluntarily decide to participate in it. Their eligibility to participate in the study will be checked, and the subjects will be randomized into the study group or the control group (via stratified randomization) based on the severity of their disease and the surgery method. The study group will receive treatment for fracture (fixation) and SurgiFill™ injection, and the control group will receive only fracture treatment. For the fracture treatment, open-reduction internal fixation, a surgery method that involves incision of the fractured area and fixation with a metal plate or a metal nail, will be performed. They will be asked to follow the guidelines of the investigators during the study and to visit the hospital seven times, including for screening. At each visit, the subjects will undergo an examination with doctors and a X-ray procedure to evaluate the safety and efficacy of SurgiFill™.

• Study Type: Interventional
• Enrollment (Actual): 60
• Phase: Not Applicable

Contacts and Locations

Study Locations

• South Korea
  • Daejeon
    • Daejeon, Daejeon, South Korea
      • Daejeon Sun Hospital
  • Gyeonggi-do
    • Uijeongbu-si, Gyeonggi-do, South Korea
      • The Catholic University of Korea Uijeongbu St. Mary's Hospital
  • Seoul
    • Seoul, Seoul, South Korea, 137701
      • The Catholic University of Korea Seoul St. Mary'S Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: Yes

Description

Inclusion criteria:

1. Patients with closed fracture out of the joint from below the trochanter of the femur up to the distal femur or in the tibia
2. Patients who agreed to participate in the study and signed the informed consent form

Exclusion criteria:

1. Patients or their family members with a history of an or an ongoing autoimmune disease
2. Patients with a history of anaphylactic response
3. Patients with hypersensitivity to grafting materials
4. Patients with hypersensitivity to porcine protein
5. Patients with osteomyelitis in the surgery area
6. Patients who are pregnant, breastfeeding, or planning to become pregnant
7. Patients with other tumors or a non-curable disease
8. Patients with a history of radiation therapy or cancer treatment within two years (Those who show normal or insignificant test results may be enrolled in this study and receive the SurgiFill™ injection based on the investigator's judgment.)
9. Patients with diabetes (Those who maintain a normal blood sugar level and did not develop complications may receive the SurgiFill™ injection based on the investigator's judgment, but the doctor's confirmation is required.)
10. Patients with an infection that required hospitalization for antibiotics or the administration of antiseptic agents
11. Patients who have been undergoing adrenocortical hormone therapy (Those who show normal or insignificant test results may be enrolled in this study and receive the SurgiFill™ injection based on the investigator's judgment.)
12. Patients with liver, heart, or kidney disease (Those who show normal or insignificant test results may be enrolled in this study and receive the SurgiFill™ injection based on the investigator's judgment. Hypertension patients are allowed.)
13. Patients who had been infected with a virus (Those who show normal or insignificant test results may be enrolled in this study and receive the SurgiFill™ injection based on the investigator's judgment.)
14. Patients with chronic renal failure or an endocrine system disease (Those who show normal or insignificant test results may be enrolled in this study and receive the SurgiFill™ injection based on the investigator's judgment.)
15. Patients who are considered inappropriate for participation in this study due to their condition (e.g., a mental illness) based on the investigator's judgment
16. Patients who had participated in another clinical trial (limited to those who participated in other studies on fracture within the last six months.)

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: SurgiFill™ on femur or tibia fracture; The study group will receive treatment for fracture and SurgiFill™ injection.	Procedure: femur or tibia fracture; For the fracture treatment, open-reduction internal fixation, a surgery method that involves incision of the fractured area and fixation with a metal plate or a metal nail, will be performed.; Other Names: Treatment for fracture; open-reduction internal fixation; Device: SurgiFill™; SurgiFill™ is a gel-type high-purity ateolcollagen for bone grafting. SurgiFill™ is an injection type.
Active Comparator: Treatment on femur or tibia fracture; The control group will receive only fracture treatment.	Procedure: femur or tibia fracture; For the fracture treatment, open-reduction internal fixation, a surgery method that involves incision of the fractured area and fixation with a metal plate or a metal nail, will be performed.; Other Names: Treatment for fracture; open-reduction internal fixation

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Bone formation completion date	The investigators will evaluate the bone formation and record the date of completion of the bone formation. The criteria for the bone formation completion are when the third callus has formed completely and when the patient no longer feels pain when he or she bears his or her full weight on his or her treated leg.	at time of bone formation completion

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Callus Formation Score change	From the results of the X-rays at six, 10, 13, 16, and 22 weeks and every eight weeks thereafter, the investigators and radiographers will confirm if there is a new callus on the X-ray results; and if there is, they will record the scores separately (not together) from 0-2 and add them up.	post-op 6,10,13,16,22 weeks, and every 8 weeks thereafter.
Detailed callus formation date	The investigators and radiographers will record the periods of the first, second, third, and fourth callus formation and endosteal healing.	at the periods of the first, second, third, and fourth callus formation and endosteal healing.
Date of full weight bearing	The investigators and radiographers will record the date when the patient can already bear his or her full weight on the treated leg.	at time of full weight bearing available

Collaborators and Investigators

• Sponsor: Cellontech Co., Ltd.
• Investigators: Principal Investigator: Jun Bum Kim, MD, Daejeon Sun Hospital; Principal Investigator: Young Wook Yim, MD, The Catholic University of Korea; Principal Investigator: Jae Kwan Kong, MD, The Catholic University of Korea, Uijeongbu St. Mary's Hospital

Study record dates

Study Major Dates

• Study Start: February 1, 2013
• Primary Completion (Actual): August 1, 2016
• Study Completion (Actual): December 1, 2016

Study Registration Dates

• First Submitted: August 28, 2015
• First Submitted That Met QC Criteria: April 2, 2026
• First Posted (Actual): April 9, 2026

Study Record Updates

• Last Update Posted (Actual): April 9, 2026
• Last Update Submitted That Met QC Criteria: April 2, 2026
• Last Verified: August 1, 2015

More Information

Terms related to this study

• Keywords: bone graft; Collagen; Femoral and Tibial Fracture
• Additional Relevant MeSH Terms: Wounds and Injuries; Leg Injuries; Fractures, Bone; Femoral Fractures; Tibial Fractures; Therapeutics
• Other Study ID Numbers: 01SGF